← Back to all trials
Recruiting
NCT07143110
LUNG-ROLL: Treatment Patterns and Cost of Illness of Lung Cancer in Canada
Conditions: Lung Neoplasms
Sex: All
Ages: 18 Years – 130 Years
Healthy volunteers: No
Enrollment: 60000
Sponsor: AstraZeneca
Location: Research Site Calgary Alberta
Summary
LUNG-ROLL is a retrospective cohort study that will describe the contemporary treatment patterns, prevalence and incidence, patient demographic and clinical characteristics, clinical outcomes, and healthcare resource use/costs for patients with lung cancer in Canada (specifically, Alberta and Ontario) using administrative data.
Eligibility Criteria
Inclusion Criteria:
* Patients with lung cancer between January 1, 2018 and end of the Selection Period.
* Patient is 18 years of age or older on diagnosis date.
* Patient has at least 12 months of health insurance coverage prior to the diagnosis date.
Exclusion Criteria:
* Diagnosed with any other cancer in the 5-year period prior to January 1, 2018.
* Diagnosed with any other cancer concurrently (i.e., on the same date) as lung cancer diagnosis.
* Invalid or incomplete records for key variables (e.g., missing year of diagnosis, missing cancer type).
* Non-Ontario or non-Alberta resident on diagnosis date.
Source: ClinicalTrials.gov (NCT07143110). StuddyBuddy aggregates publicly available trial information.